Temasek led a $80m Series B round in Mojia Biotech.

Temasek, a global investment company, led a $80m Series B round in Mojia Biotech, a fast-growing, product-focused bio-manufacturing company, with participation from LYZZ Capital, Sento Investment, Bits x Bites and Asia Green. "Over the last decade, we have established a comprehensive R&D platform combining biology, chemistry, engineering and polymer sciences, accumulated hands-on experiences in large-scale bio-production and built strong global commercialization capabilities. Our green technology is a prove that it is possible to address environmental pollution associated with traditional chemical industry yet achieving cost advantage and performance supercity. We greatly appreciate visionary and like-minded investors like Temasek, Asia Green Fund, Bits x Bites and LYZZ Capital in supporting our mission for sustainable development and carbon neutrality," Ansen Chiew, Mojia Biotech co-founder.